|Day's Range||1.11 - 1.14|
|52 Week Range||0.93 - 1.47|
|PE Ratio (TTM)||3.42|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Intercept Pharmaceuticals, Inc. (ICPT) announced that livver drug Ocaliva has obtained approval in Canada also.
Roche Holding AG (RHHBY) announced new retrospective data analyses for idiopathic pulmonary fibrosis (IPF) drug, Esbriet.
Inovio Pharmaceuticals Inc. (INO) shares have rallied 12% since the company announced that its HIV vaccine evoked almost 100% immune response rates in a clinical study